Virtu Financial’s Corcept Therapeutics CORT Stock Holding History

Virtu Financial’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$448K	Buy	+5,155	New	+$311K	0.01%	572
2026 Q1	–	Sell	-13,099	Closed	-$456K	–	1725
2025 Q4	$456K	Buy	+13,099	New	+$1.03M	0.02%	647
2023 Q4	–	Sell	-8,324	Closed	-$227K	–	1629
2023 Q3	$227K	Buy	+8,324	New	+$241K	0.02%	613
2019 Q4	$269K	Buy	+22,205	New	+$309K	0.03%	748
2019 Q1	–	Sell	-13,647	Closed	-$182K	–	1462
2018 Q4	$182K	Buy	+13,647	New	+$180K	0.01%	997
2018 Q3	–	Sell	-10,620	Closed	-$167K	–	1616
2018 Q2	$167K	Sell	10,620 -1,936	-15%	-$33.7K	0.01%	1553
2018 Q1	$207K	Buy	+12,556	New	+$233K	0.01%	1337

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's CORT Position: Q2 2026 in Review

Virtu Financial opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 5,155 shares worth $448K. The stake represents 0.01% of the portfolio and ranks #572 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CORT as recently as Q4 2025.

Virtu Financial first reported a position in CORT in Q1 2018 and has held it in 7 quarters since. The position peaked at $456K in Q4 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Virtu Financial held 5,155 shares of Corcept Therapeutics worth $448K as of Q2 2026.
Corcept Therapeutics was a new Virtu Financial position in Q2 2026.
Corcept Therapeutics made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #572 holding.
Virtu Financial first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 7 quarters since.
Virtu Financial's Corcept Therapeutics position peaked at $456K in Q4 2025.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.